Mulu Tesfay

Mulu Tesfay is an Instructor in the Experimental Pathology Division at the University of Arkansas for Medical Sciences (UAMS) College of Medicine Department of Pathology. His research focuses on translational immunovirotherapy for advanced hepatopancreatobiliary (HPB) cancers and addressing health disparities in cancer therapy and research.

Educational Background:

• Bachelor's degree from Alemaya University, Ethiopia
• MSc in Molecular Biology from Catholic University of Leuven, Belgium
• MSc in Biological Sciences from Northern Illinois University
• PhD in Microbiology and Immunology from LSU Health Sciences Center in Shreveport

Research and Grants: Dr. Tesfay is a Co-Investigator on an AACR grant developing virotherapy for pancreatic cancer. His work bridges immunovirotherapy, cancer biology, and health disparities, with a focus on translational approaches for advanced HPB cancers.

Professional Affiliations:

• Africa HepatoPancreatoBiliary Cancer Consortium
• NIDDK Network of Minority Health Research Investigators
• Society for Immunotherapy of Cancer (SITC)
• American Association for Cancer Research (AACR)
• American Society of Gene & Cell Therapy (ASGCT)

Scientific Awards:

• Travel award from the National Institutes of Health (NIH)
• Travel award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Travel award from the American Society for Virology

Previous Experience: Senior scientist at Imanis Life Sciences, and postdoctoral fellowships at the Mayo Clinic's Department of Molecular Medicine and UAMS.